Fact CheckerSign in

NCT04783571Active, not recruiting

Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia

Source: ClinicalTrials.gov · Last updated 13 May 2026

Brief summary (registry, in English)

The investigators will test the hypothesis that auditory stimulation (playing quiet sounds during sleep) can normalize brain activity during sleep and improve memory in patients with schizophrenia. The investigators will do this by measuring sleep and memory performance under two conditions separated by one week: receiving auditory stimulation during sleep and not receiving auditory stimulation during sleep. The investigators will study healthy subjects and outpatients with schizophrenia.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
19 Feb 2021
Start date
13 Apr 2020
Primary completion date
31 Dec 2027
Lead sponsor
Massachusetts General Hospital
NCT number
NCT04783571

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 13 Apr 2020 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current use of psychotropic medications (healthy controls only)

Other illness

  • A history of head injury resulting in prolonged loss of consciousness or other neurological sequelae
  • Neurological disorder (including seizure disorder)
  • Any unstable chronic medical condition that affects sleep
  • Diagnosed sleep disorder

Other

  • Pregnant females
  • IQ \<85
  • Significant hearing or vision loss
  • Current substance abuse or dependence (nicotine abuse or dependence is not exclusionary)

Who the study is looking for

  • For healthy controls:
  • Male and female subjects
  • 18-50 years of age
  • Proficient in English
    • For schizophrenia patients:
  • Male and female schizophrenia outpatients
  • 18-50 years of age
  • Proficient in English
  • Able to give informed consent

Age in the registry: 18 years to 50 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Massachusetts General Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.